Transplantation

GRAFNOS

Active Ingredient: Tacrolimus Capsule

Strength: 0.25 mg/ 0.5 mg / 1 mg / 2mg

Dosage form: Capsule

Route of Administration: Oral

Class of Drug: Immunosuppressant

Pack Details: 1x10 Tablets

Indication:
1. Prophylaxis of organ rejection in patients receiving allogeneic liver, kidney or heart transplants
2. Use concomitantly with mycophenolate mofetil and corticosteroids

CONVOTOS

Active Ingredient: Mycophenolate Mofetil

Strength: 250 mg/ 500 mg

Dosage form: Tablet

Route of Administration: Oral

Class of Drug: Immunosuppressant

Pack Details: 1x10 Tablets

Indication:
1. Prophylaxis of organ rejection in patients receiving allogeneic liver, kidney or heart transplants
2. Use concomitantly with Tacrolimus and corticosteroids

CONVOTOS-S

Active Ingredient(s): Mycophenolate Sodium

Strength: 180 mg / 360 mg

Dosage form: Tablet

Route of Administration: Oral

Class of Drug: Immunosuppressant

Pack Details: 1x10

Indication:
1. Prophylaxis of organ rejection in patients receiving allogeneic liver, kidney or heart transplants
2. Use concomitantly with Tacrolimus and corticosteroids
3. Mycophenolate sodium provides an alternative to Mycophenolate mofetil in Transplant Patients to avoid GI complications

VYLSTER

Active Ingredient(s): Valganciclovir

Strength: 450 mg

Dosage form: Tablet

Route of Administration: Oral

Class of Drug: Anti-viral drug

Pack Details: 1x2

Indication:
1.Drug of Choice for both Prophylaxis & treatment of CMV disease in kidney, heart, or kidney-pancreas transplant patients at high risk
2. Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)
3. Prevention of CMV disease in kidney or heart transplant paediatric patients at high risk.